Ethavex-100 Disease Interactions
There are 2 disease interactions with Ethavex-100 (ethaverine).
Papaverine derivatives (applies to Ethavex-100) complete AV heart block
Major Potential Hazard, High plausibility.
The use of papaverine and papaverine derivatives is contraindicated in patients with complete AV heart block. When conduction is depressed, these agents can induce transient ectopic rhythms of ventricular origin, either premature beats or paroxysmal tachycardia. Therapy with these agents should be administered cautiously in patients with conduction disturbances, including sinus bradyarrhythmia and partial or first-degree AV block.
Papaverine derivatives (applies to Ethavex-100) glaucoma
Moderate Potential Hazard, High plausibility. Applicable conditions: Glaucoma/Intraocular Hypertension
The use of papaverine derivatives has been associated with an increase in intraocular pressure. Therapy with papaverine derivatives should be administered cautiously in patients with glaucoma.
Switch to professional interaction data
Ethavex-100 drug interactions
There are 93 drug interactions with Ethavex-100 (ethaverine).
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.